Skip to main content

Table 7 Association between POAF and duration of stay as well as duration of ventilation

From: A double-blind randomised controlled trial on the effect of Tocovid, a tocotrienol-rich capsule on postoperative atrial fibrillation at the National Heart Institute, Kuala Lumpur: an interim blinded analysis

Duration Total, median ± IQR / n (%) Non-POAF group, median ± IQR / n (%) POAF group, median ± IQR /n (%) p-value
Duration in ICU (min) 2767.50 ± 3927 1742 ± 2354 3847.50 ± 4773 0.01*
Duration in HDU (min) 1522.50 ± 1584 1480 ± 1514 1755 ± 2743 0.33
Duration of ventilation (min) 1187.50 ± 442 1157 ± 391 1230 ± 875 0.22
Duration of hosp. stay (day) 8.0 ± 3 7.0 ± 3 9.0 ± 3 0.04*
Reintubation     0.045**
Yes 4 (2.6) 1 (25) 3 (75)  
No 152 (97.4) 117 (77.0) 35 (23.0)  
  1. Total n varies slightly for each item due to a small amount of missing data in each
  2. ICU intensive care unit, HDU high dependency unit
  3. *p value significant at < 0.05 using Mann–Whitney Test
  4. **p value significant at < 0.05 using Fisher Exact test